Synodos is a new application-based consortium which is encouraging highly collaborative, interdisciplinary, multi-institutional, translational research involving basic, applied, and clinical science. Synodos for NF2 was the first fully-integrated neurofibromatosis type 2 (NF2) research project to directly advance the NF2 field through translational and clinical research.
The Children’s Tumor Foundation is now embarking upon a new consortium in Synodos for NF1. The end goal is to fund new approaches to the diagnosis and treatment of NF1, especially directed at low grade gliomas and innovative ways to make better, faster decisions regarding the potential efficacy of treatments.
Synodos requires collaboration between basic biologists, animal pharmacologists, imagers, clinicians, and industry partners who will work together in this next, and perhaps most important, step in finding treatments and a cure for NF1.
For more information and application specifications, please click here.
Full applications due by 5:00 p.m. EST on Friday, January 16, 2015.
